PT
NVO

Plimoth Trust’s Novo Nordisk NVO Stock Holding History

Plimoth Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,275
Closed -$218K – 177
2025
Q4 		$218K Sell
4,275
-1,420
-25% -$72.6K 0.05% 169
2025
Q3 		$316K Sell
5,695
-205
-3% -$12K 0.07% 145
2025
Q2 		$407K Buy
5,900
+10
+0.2% +$680 0.1% 129
2025
Q1 		$409K Buy
5,890
+245
+4% +$20.2K 0.11% 129
2024
Q4 		$486K Buy
+5,645
New +$610K 0.12% 122

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Plimoth Trust's NVO Position: Q1 2026 in Review

Plimoth Trust sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,275 shares — an estimated $218K sold.

Plimoth Trust first reported a position in NVO in Q4 2024 and held it in 5 quarters. The position peaked at $486K in Q4 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Plimoth Trust reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Plimoth Trust sold 4,275 Novo Nordisk shares in Q1 2026, an estimated $218K.
  • Plimoth Trust first reported a position in Novo Nordisk in Q4 2024 and held it in 5 quarters.
  • Plimoth Trust's Novo Nordisk position peaked at $486K in Q4 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Plimoth Trust's 13F filing for Q1 2026, filed 27 Apr 2026.